Overview

PT150 Drug for Use in Alcohol Use Disorder

Status:
RECRUITING

Trial end date:
2028-07-31

Target enrollment:

Participant gender:

Summary

The goal of this study is to learn if PT150 can reduce the behavioral and physical effects of stress, alcohol, and alcohol use in people with alcohol use disorder.

Phase:

PHASE1

Details

Lead Sponsor:

Pop Test Oncology LLC

Collaborators:

National Institute on Alcohol Abuse and Alcoholism (NIAAA)
University of Kentucky

Treatments:

(11R,13S,17S)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta(a)phenanthren-3-one
Ethanol